Brief: Teleflex Receives FDA 510(K) Clearance For Expanded Indications Of The QuikClot Control+™ Hemostatic Device
30/04/2025 12:25
April 30 (Reuters) - Teleflex Inc TFX.N: TELEFLEX RECEIVES FDA 510(K) CLEARANCE FOR EXPANDED INDICATIONS OF THE QUIKCLOT CONTROL+™ HEMOSTATIC DEVICE Source text: ID:nGNX1YprB0 Further company coverage: TFX.N ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Teleflex Incorporated
See all newsBrief: UK's CMA Issues Invitation to Comment on Intersurgical-Teleflex Transaction
Competition and Mkts - Merger Update: Intersurgical / Teleflex
Teleflex Incorporated reports results for the quarter ended June 30 - Earnings Summary
Teleflex Q2 revenue rises 29%, beats analyst estimates
US FDA approves first freeze-dried plasma product (updated)